85 related articles for article (PubMed ID: 22440655)
21. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis.
Maeshima Y; Yerramalla UL; Dhanabal M; Holthaus KA; Barbashov S; Kharbanda S; Reimer C; Manfredi M; Dickerson WM; Kalluri R
J Biol Chem; 2001 Aug; 276(34):31959-68. PubMed ID: 11399763
[TBL] [Abstract][Full Text] [Related]
22. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
Min HY; Doyle LV; Vitt CR; Zandonella CL; Stratton-Thomas JR; Shuman MA; Rosenberg S
Cancer Res; 1996 May; 56(10):2428-33. PubMed ID: 8625323
[TBL] [Abstract][Full Text] [Related]
23. [The cloning and expression of angiogenic inhibitor tumstatin(45-132) in E. coli].
Luo YQ; Wang LH; Qiu Y; Jiao BH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):141-3. PubMed ID: 15766393
[TBL] [Abstract][Full Text] [Related]
24. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
He GA; Luo JX; Zhang TY; Wang FY; Li RF
Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836
[TBL] [Abstract][Full Text] [Related]
25. Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer.
Filleur S; Volz K; Nelius T; Mirochnik Y; Huang H; Zaichuk TA; Aymerich MS; Becerra SP; Yap R; Veliceasa D; Shroff EH; Volpert OV
Cancer Res; 2005 Jun; 65(12):5144-52. PubMed ID: 15958558
[TBL] [Abstract][Full Text] [Related]
26. Expression of soluble, biologically active recombinant human tumstatin in Escherichia coli.
Luo YQ; Wang LH; Yi Q; Jiao BH
Clin Exp Med; 2008 Mar; 8(1):37-42. PubMed ID: 18385939
[TBL] [Abstract][Full Text] [Related]
27. Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin.
Folkman J
Sci STKE; 2006 Sep; 2006(354):pe35. PubMed ID: 17003465
[TBL] [Abstract][Full Text] [Related]
28. The YSNSG cyclopeptide derived from tumstatin inhibits tumor angiogenesis by down-regulating endothelial cell migration.
Thevenard J; Ramont L; Devy J; Brassart B; Dupont-Deshorgue A; Floquet N; Schneider L; Ouchani F; Terryn C; Maquart FX; Monboisse JC; Brassart-Pasco S
Int J Cancer; 2010 Mar; 126(5):1055-66. PubMed ID: 19551865
[TBL] [Abstract][Full Text] [Related]
29. B-type natriuretic peptide enhances vasculogenesis by promoting number and functional properties of early endothelial progenitor cells.
Shmilovich H; Ben-Shoshan J; Tal R; Afek A; Barshack I; Maysel-Auslander S; Harats D; Keren G; George J
Tissue Eng Part A; 2009 Sep; 15(9):2741-9. PubMed ID: 19275472
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of possible approaches to angiogenesis regulation in vitro with the help of recombinant fragments of angiogenesis inhibitors such as endostatin, tumstatin and PEDF].
Kuznetsov SL; Likhvantseva VG; Arutiunian EV; Kuz'min KA; Sel'kov SA; Sokolov DI
Vestn Ross Akad Med Nauk; 2013; (4):63-7. PubMed ID: 24003724
[TBL] [Abstract][Full Text] [Related]
31. Anti-angiogenic cues from vascular basement membrane collagen.
Colorado PC; Torre A; Kamphaus G; Maeshima Y; Hopfer H; Takahashi K; Volk R; Zamborsky ED; Herman S; Sarkar PK; Ericksen MB; Dhanabal M; Simons M; Post M; Kufe DW; Weichselbaum RR; Sukhatme VP; Kalluri R
Cancer Res; 2000 May; 60(9):2520-6. PubMed ID: 10811134
[TBL] [Abstract][Full Text] [Related]
32. Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma.
Levine HA; Pamuk S; Sleeman BD; Nilsen-Hamilton M
Bull Math Biol; 2001 Sep; 63(5):801-63. PubMed ID: 11565406
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for the functions of endogenous angiogenesis inhibitors.
Grant MA; Kalluri R
Cold Spring Harb Symp Quant Biol; 2005; 70():399-410. PubMed ID: 16869777
[TBL] [Abstract][Full Text] [Related]
35. Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.
Chen P; Yin H; Wang Y; Mi J; He W; Xie L; Wang Y
Mol Vis; 2010 Feb; 16():310-9. PubMed ID: 20208988
[TBL] [Abstract][Full Text] [Related]
36. Angiogenic effects of adrenomedullin in ischemia and tumor growth.
Iimuro S; Shindo T; Moriyama N; Amaki T; Niu P; Takeda N; Iwata H; Zhang Y; Ebihara A; Nagai R
Circ Res; 2004 Aug; 95(4):415-23. PubMed ID: 15242974
[TBL] [Abstract][Full Text] [Related]
37. Vascular basement membrane-derived multifunctional peptide, a novel inhibitor of angiogenesis and tumor growth.
Cao JG; Peng SP; Sun L; Li H; Wang L; Deng HW
Acta Biochim Biophys Sin (Shanghai); 2006 Jul; 38(7):514-21. PubMed ID: 16820868
[TBL] [Abstract][Full Text] [Related]
38. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
39. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
Vandercappellen J; Liekens S; Bronckaers A; Noppen S; Ronsse I; Dillen C; Belleri M; Mitola S; Proost P; Presta M; Struyf S; Van Damme J
Mol Cancer Res; 2010 Mar; 8(3):322-34. PubMed ID: 20215425
[TBL] [Abstract][Full Text] [Related]
40. Effects of eukaryotic expression plasmid encoding human tumstatin gene on endothelial cells in vitro.
Yang YP; Xu CX; Hou GS; Xin JX; Wang W; Liu XX
Chin Med J (Engl); 2010 Aug; 123(16):2269-73. PubMed ID: 20819678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
